March 25, 2026 – Cognito Therapeutics, a late clinical-stage neurotechnology company pioneering non-invasive neuroprotective therapies in neurodegenerative diseases, today announced a collaboration with Ochsner Health, a leading health system serving Louisiana, Mississippi and the Gulf South, to launch a Brain Health Collaboratory aimed at advancing new approaches to treating cognitive decline and Alzheimer’s disease.
The Ochsner Collaboratory establishes the Gulf South’s first statewide platform for non-invasive brain health innovation, combining Cognito’s investigational Spectris technology platform with Ochsner’s expansive clinical network to explore new models for brain health care delivery across both urban and rural communities throughout the region.